Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank8
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-62.94M
↓ 63% vs avg
Percentile
P8
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
$-38.71M
Historical baseline
PeriodValueYoY Change
TTM$-62.94M+27.7%
2024$-87.00M-75.4%
2023$-49.60M-16.5%
2022$-42.56M-650.7%
2021$7.73M+237.8%
2020$-5.61M+72.4%
2019$-20.34M+63.6%
2018$-55.90M-67.5%
2017$-33.37M+11.0%
2016$-37.48M-